By Product
-
Services
-
Software
By Modality
-
Computed Tomography
-
Magnetic Resonance Imaging
-
Positron Emission Tomography
-
Ultrasound
-
X-Ray
-
Others
By Therapeutic Area
-
Oncology
-
Neurology
-
Cardiovascular
-
Others
By End User
-
Pharmaceutical and Biotechnology Companies
-
Contract Research Organizations
-
Medical Device Companies
-
Others
By Trial Phase
-
Phase I
-
Phase II
-
Phase III
-
Phase IV
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Clario, Calyx, ICON, Medpace, Imaging Endpoints, Median Technologies, WCG Intrinsic Imaging, Image Analysis Group, Medidata, Perspectum, Flywheel, Altis Labs, Biotrial, Banook, QMENTA, Medical Metrics, Brainomix, Quibim and Invicro.
Key opportunities include AI-derived imaging biomarkers, new PET tracers and radiopharmaceutical therapies, cloud-based imaging platforms, and regional harmonization of trial regulation in Asia Pacific, Latin America and Africa.
Growing use of imaging endpoints in oncology and neurology pipelines, together with outsourcing of imaging work to specialist providers, is the main growth factor, supported by cloud platforms and AI tools.
Services, Software are the sub segmBy Product, the Services segment dominated the market in 2025 with an estimated 69.30% share, supported by core laboratory reads, quality control and endpoint management.ents of Clinical Trial Imaging market.
North America dominated the market with a share of 42.51% in 2025, driven by the concentration of sponsors, imaging core laboratories and academic trial centers.